Skip to content

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Nov 7, 2017
SAN DIEGO, Nov. 7, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), today provided a corporate update and reported financial results for the third quarter ended September 30, 2017. "We are pleased with the progress we achieved during the third quarter, hitting multiple milestones for our lead programs," said Amit D. Munshi, P...
Oct 30, 2017
SAN DIEGO, Oct. 30, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that the Company will release its third quarter 2017 financial results and provide a corporate update on Tuesday, November 7, 2017, after the close of the U.S. financial markets.  The Company will host a conference call and live webcast with the inv...
Aug 7, 2017
SAN DIEGO, Aug. 7, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today provided a corporate update and reported financial results for the second quarter ended June 30, 2017. "We are excited about the continued t...
Jul 31, 2017
SAN DIEGO, July 31, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that the Company will release its second quarter 2017 financial results and provide a corporate update on Monday, August 7, 2017, after the close of the U.S. financial markets.  The Company will host a conference call and live webcast with the inves...
May 9, 2017
SAN DIEGO, May 9, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today provided a corporate update and reported financial results for the first quarter ended March 31, 2017. "With important clinical data expected...
May 2, 2017
SAN DIEGO, May 2, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that the Company will release its first quarter 2017 financial results and provide a corporate update on Tuesday, May 9, 2017, after the c...
Mar 14, 2017
SAN DIEGO, March 14, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today provided a corporate update and reported financial results for the fourth quarter and full-year ended December 31, 2016. "We are very plea...
Mar 6, 2017
SAN DIEGO, March 06, 2017 (GLOBE NEWSWIRE) -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14, 2017, after the close of the U.S. financial markets.  The Company will host a conference call and live w...
Nov 7, 2016
SAN DIEGO, Nov. 7, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), today reported financial results for the third quarter ended September 30, 2016, and provided a corporate update. "This was a highly productive quarter for Arena.  We continue to make significant progress focusing the company on our unpartnered clinical p...
Oct 31, 2016
SAN DIEGO, Oct. 31, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Monday, November 7, 2016, after the close of the U.S. financial markets.  The Company will host a conference call and live webcast with the inve...
Aug 8, 2016
SAN DIEGO, Aug. 8, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), today reported financial results for the second quarter ended June 30, 2016, and provided a corporate update. "We are continuing to successfully execute the turnaround and transition of Arena from a historically research-oriented organization to a high perfor...
Aug 1, 2016
SAN DIEGO, Aug. 1, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that the Company will release its second quarter 2016 financial results and provide a corporate update on Monday, August 8, 2016, after the close of the U.S. financial markets.  The Company will host a conference call and live webcast with the invest...
May 9, 2016
SAN DIEGO, May 9, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the first quarter ended March 31, 2016, and provided a corporate update. "We have continued to focus on the strategic priorities that we outlined last October, including advancing APD371 through Phase 1b and entering into a ...
May 2, 2016
SAN DIEGO, May 2, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on Monday, May 9, 2016, to discuss first quarter 2016 financial results and provide a corporate update. Arena will issue a press release with its financi...
Feb 29, 2016
SAN DIEGO, Feb. 29, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the fourth quarter and full year ended December 31, 2015, and provided a corporate update. "Arena took a number of important steps in 2015, including initiating two Phase 2 clinical trials, partnering two of our programs, ...
Page:
...
Next Last
 
= add release to Briefcase